Laval, Canada

Boulos Zacharie

USPTO Granted Patents = 29 


 

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 293(Granted Patents)


Location History:

  • Rapides, CA (1995)
  • Québec, CA (2014 - 2015)
  • Quebec, CA (1994 - 2017)
  • Laval, CA (1992 - 2022)

Company Filing History:


Years Active: 1992-2022

Loading Chart...
Loading Chart...
Loading Chart...
29 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Boulos Zacharie in Pharmaceutical Science

Introduction: Boulos Zacharie, based in Laval, Canada, is a prolific inventor with a remarkable portfolio of 29 patents. His work primarily focuses on the development of novel pharmaceutical compounds aimed at treating various health conditions. With a strong emphasis on scientific innovation, Zacharie has contributed significantly to advancements in the field of medicine.

Latest Patents: Among his latest inventions are two significant patents that detail his research on substituted aromatic compounds. The first patent describes compounds that serve as potential treatments for fibrosis, involving properties of various alkyl and aromatic groups. The second patent expands on substituted aromatic compounds and highlights their pharmaceutical applications in addressing diseases such as blood disorders, renal disorders, inflammatory-related diseases, and oxidative stress-related conditions. These innovations demonstrate Zacharie's commitment to improving healthcare through advanced chemical formulations.

Career Highlights: Throughout his career, Boulos Zacharie has worked with reputable organizations such as Prometic Biosciences Inc. and Biochem Pharma Inc. His tenure at these companies has been marked by the successful research and development of pharmaceutical compounds that have the potential to improve patient outcomes. His expertise in medicinal chemistry and pharmaceutical sciences has placed him at the forefront of innovative drug development.

Collaborations: Zacharie has had the opportunity to collaborate with talented professionals in the field, including notable coworkers like Lyne Gagnon and Christopher L. Penney. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment that encourages scientific discovery and innovation.

Conclusion: Boulos Zacharie's contributions to pharmaceutical science are marked by a diverse range of patents and collaborative efforts. His latest innovations in substituted aromatic compounds illustrate the potential for new treatments that can address significant health issues. As he continues to advance his research, Zacharie remains a pivotal figure in the landscape of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…